# AMN Healthcare Services Inc: Form 10-Q for the period ended Jun 30, 2015

- Company: [AMN Healthcare Services Inc](/companies/amn.md) (CIK 1142750)
- Form: 10-Q
- Filed: 2015-08-06
- Accepted by EDGAR: Aug 5, 2015, 20:01 ET
- Period: 2015-06-30
- Accession: 0001142750-15-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1142750/000114275015000009/ahs-20150630x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1142750/000114275015000009/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-04-01 to 2015-06-30 | $350.1m | us-gaap:Revenues |
| Revenue | 6 months, 2015-01-01 to 2015-06-30 | $677.7m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2015-04-01 to 2015-06-30 | $240.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2015-01-01 to 2015-06-30 | $466.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2015-04-01 to 2015-06-30 | $110.1m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2015-01-01 to 2015-06-30 | $211.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2015-04-01 to 2015-06-30 | $74.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2015-01-01 to 2015-06-30 | $146.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2015-04-01 to 2015-06-30 | $30.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2015-01-01 to 2015-06-30 | $54.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-04-01 to 2015-06-30 | $2.0m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2015-01-01 to 2015-06-30 | $3.8m | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-04-01 to 2015-06-30 | $12.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2015-01-01 to 2015-06-30 | $23.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-04-01 to 2015-06-30 | $15.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2015-01-01 to 2015-06-30 | $28.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.32 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2015-01-01 to 2015-06-30 | $0.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.33 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2015-01-01 to 2015-06-30 | $0.59 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-04-01 to 2015-06-30 | 48,863,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2015-01-01 to 2015-06-30 | 48,615,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2015-01-01 to 2015-06-30 | $33.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2015-01-01 to 2015-06-30 | $14.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2015-06-30 | $14.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-06-30 | $343.4m | us-gaap:AssetsCurrent |
| Total assets | at 2015-06-30 | $826.2m | us-gaap:Assets |
| Current liabilities | at 2015-06-30 | $231.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-06-30 | $538.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2015-06-30 | $288.0m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 39,850 characters.

### of Operations

The following discussion should be read in conjunction with our consolidated financial statements and the notes thereto and other financial information included elsewhere herein and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, filed with the SEC on February 25, 2015 (“2014 Annual Report”). Certain statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are “forward-looking statements.” See “Special Note Regarding Forward-Looking Statements.” We undertake no obligation to update the forward-looking statements in this Quarterly Report. References in this Quarterly Report to “AMN Healthcare,” the “Company,” “we,” “us” and “our” refer to AMN Healthcare Services, Inc. and its wholly owned subsidiaries.

### Overview

We are the innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. As an innovative workforce solutions partner, our managed services programs, or “MSP,” vendor management systems, or “VMS,” recruitment process outsourcing, or “RPO,” workforce consulting services, predictive modeling, staff scheduling and the placement of physicians, nurses and allied healthcare professionals into temporary and permanent positions enable our clients to successfully reduce staffing complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. Our clients include acute and sub-acute care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, and several other healthcare settings. Our clients utilize our workforce solutions and healthcare staffing services to manage their clinical workforce needs, both temporary and permanent, in an economically beneficial manner. Our managed services program and vendor management systems enable healthcare organizations to increase their efficiency by managing all of their supplemental workforce needs through one company or technology.

We conduct business through three reportable segments: nurse and allied healthcare staffing, locum tenens staffing, and physician permanent placement services. For the three months ended June 30, 2015, we recorded revenue of $350.1 million, as compared to $250.9 million for the same period last year. For the three months ended June 30, 2015, we recorded net income of $15.9 million, as compared to $7.2 million for the same period last year. For the six months ended June 30, 2015, we recorded revenue of $677.7 million, as compared to $491.8 million for the same period last year. For the six months ended June 30, 2015, we recorded net income of $28.1 million, as compared to $14.8 million for the same period last year.

On January 7, 2015, we completed the acquisition of Onward Healthcare, including its two wholly-owned subsidiaries, Locum Leaders and Medefis (collectively, “OH”). Onward Healthcare is a national nurse and allied healthcare staffing firm, Locum Leaders is a national locum tenens provider, and Medefis is a leading provider of a software as a service, or “SaaS,” based vendor management system for healthcare facilities. The results of Onward Healthcare and Medefis are included in our nurse and allied healthcare staffing segment and the results of Locum Leaders are included in our locum tenens staffing segment since the date of acquisition. In addition, during the fourth quarter of 2014 we acquired Avantas. The results of Avantas are included in our nurse and allied healthcare staffing segment. For the three months ended June 30, 2015, approximately $38.2 million of OH and Avantas revenue and $3.6 million of OH and Avantas income before income taxes were included in the unaudited condensed consolidated statement of operations. For the six months ended June 30, 2015, approximately $71.7 million of OH and Avantas revenue and $6.3 million of OH and Avantas income before taxes were included in the unaudited condensed consolidated statement of operations.

Nurse and allied healthcare staffing segment revenue comprised 69% and 67% of total consolidated revenue for the six months ended June 30, 2015 and 2014, respectively. Through our nurse and allied healthcare staffing segment, we provide hospitals and other healthcare facilities with a range of clinical workforce solutions, including: (1) a comprehensive managed services solution in which we manage all of the temporary nursing and allied staffing needs of a client; (2) a SaaS VMS through which our clients can manage all of their temporary nursing and allied staffing needs; (3) traditional clinical staffing solutions of variable assignment lengths; (4) a recruitment process outsourcing program that leverages our expertise and support systems to replace or complement a client’s existing internal recruitment function for permanent placement needs; and (5) clinical labor consulting management services.

Locum tenens staffing segment revenue comprised 27% and 29% of total consolidated revenue for the six months ended June 30, 2015 and 2014, respectively. Through our locum tenens staffing segment, we provide (1) a comprehensive managed services solution in which we manage all of the locum tenens needs of a client; (2) a SaaS VMS through which our clients can manage all of their locum tenens needs; and (3) placement of physicians of all specialties, as well as dentists and other advanced practice providers, with clients on a temporary basis as independent contractors. These locum tenens providers are used by our healthcare facility and physician practice group clients to fill temporary vacancies created by vacation and leave schedules and to bridge the gap while they seek permanent candidates or explore expansion. Our locum tenens clients represent a diverse group of healthcare organizations throughout the United States, including hospitals, health systems, medical groups, occupational medical clinics, psychiatric facilities, government institutions and insurance entities. The professionals we place are recruited nationwide and are typically placed on multi-week contracts with assignment lengths ranging from a few days up to one year.

Physician permanent placement services segment revenue comprised 4% of total consolidated revenue for both the six months ended June 30, 2015 and 2014. Through our physician permanent placement services segment, we assist hospitals, healthcare facilities and physician practice groups throughout the United States in identifying and recruiting physicians for permanent placement. Our broad specialty offerings include over 70 specialist and sub-specialist opportunities such as internal medicine, family practice and orthopedic surgery. We perform the vast majority of our services on a retained basis through our Merritt Hawkins® brand, for which we are generally paid through a blend of retained search fees and variable fees tied to work performed and successful placement. To a smaller degree, we also perform our services on a contingent basis, exclusively through our Kendall & Davis® brand, for which fees are paid once physician candidates are ultimately hired by our clients.

### Management Initiatives

Our growth strategy focuses on providing an innovative and differentiated value and experience to our clients and healthcare professionals. To accomplish this, we offer innovative workforce solution offerings such as MSP, VMS, RPO and clinical labor management consulting in addition to traditional travel nurse and allied temporary staffing, locum tenens staffing, and physician permanent placement services. Through these differentiated services, we have built strategic relationships with our clients to assist them in improving their financial, operational and patient care results through enhanced productivity, labor optimization and candidate quality enhancement. We continually seek strategic opportunities to expand into new workforce solutions with recurring revenue streams as well as expanding our services to encompass emerging healthcare roles. At the same time, we continue to invest in our technology infrastructure and new recruitment approaches to capitalize on the demand growth we are experiencing and expect to continue due to the impact of healthcare reform, the aging population and healthcare staffing shortages within certain regions and disciplines.

### Recent Trends

The healthcare staffing environment has remained strong throughout the first half of 2015. Demand in all our staffing businesses is significantly above prior-year levels. This demand growth has translated into an increase in the number of healthcare professionals currently on assignment and increased booking levels for future assignments. On the supply side, since the beginning of 2015, we have been experiencing an increase in the number of first time healthcare professional travelers, which we believe demonstrates more willingness for healthcare professionals to work temporary assignments.

We continue to experience a high level of demand for our workforce solution programs. Comprised of ShiftWise, Avantas and Medefis along with our MSP and RPO programs, we expect that revenue attributable to our suite of workforce solutions offerings will continue to grow. The growth in revenue from these workforce solution offerings and improvement in our bill rates are contributing to our increasing gross margins. While we have increased pay rates to attract more nursing professionals into our industry to meet the increased demand, the highly competitive market for supply has allowed us to negotiate increased bill rates with many of our clients to mitigate the overall gross margin impact.

We continue to experience strong demand for our services within both the locum tenens and physician permanent placement services segments. We have also seen an increase in our sales productivity in these divisions that has translated into improved profitability.

### Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements in conformity with United States generally accepted accounting principles requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to asset impairment, accruals for self-insurance and compensation and related benefits, accounts receivable, contingencies and litigation, and income taxes. We base these estimates on the information that is currently available to us and on various other assumptions that we believe are reasonable under the circumstances. Actual results could vary from these estimates under different assumptions or conditions. If these estimates differ significantly from actual results, our consolidated financial statements and future results of operations may be materially impacted. Our critical accounting policies and estimates remain consistent with those reported in our 2014 Annual Report.

### Results of Operations

The following table sets forth, for the periods indicated, selected unaudited condensed consolidated statements of operations data as a percentage of revenue. Our results of operations include three reportable segments: (1) nurse and allied healthcare staffing; (2) locum tenens staffing; and (3) physician permanent placement services. The OH and Avantas acquisitions impact the comparability of the results between the three and six months ended June 30, 2015 and the three and six months ended June 30, 2014. Our historical results are not necessarily indicative of our future results of operations.

*Unaudited Condensed Consolidated Statements of Operations:*

|  | Three Months Ended June 30, 2015 | 2014 | Six Months Ended June 30, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of revenue | 68.6 | 69.2 | 68.8 | 69.3 |
| Gross profit | 31.4 | 30.8 | 31.2 | 30.7 |
| Selling, general and administrative | 21.3 | 22.1 | 21.6 | 22.4 |
| Depreciation and amortization | 1.5 | 1.6 | 1.5 | 1.6 |
| Income from operations | 8.6 | 7.1 | 8.1 | 6.7 |
| Interest expense, net, and other | 0.6 | 1.8 | 0.6 | 1.3 |
| Income before income taxes | 8.0 | 5.3 | 7.5 | 5.4 |
| Income tax expense | 3.5 | 2.3 | 3.4 | 2.4 |
| Net income | 4.5% | 3.0% | 4.1% | 3.0% |

### Comparison of Results for the Three Months Ended June 30, 2015 to the Three Months Ended June 30, 2014

***Revenue.*** Revenue increased 40% to $350.1 million for the three months ended June 30, 2015 from $250.9 million for the same period in 2014, due to additional revenue of approximately $38.2 million resulting from our OH and Avantas acquisitions with the remainder of the increase driven by 24% organic growth.

Nurse and allied healthcare staffing segment revenue increased 45% to $240.0 million for the three months ended June 30, 2015 from $165.9 million for the same period in 2014. Of the $74.1 million increase, approximately $29.4 million was attributable to the additional revenue in connection with the OH and Avantas acquisitions, with the remainder primarily attributable to a 13% increase in the average number of healthcare professionals on assignment, a 7% increase in the average bill rate, an increase in the average numbers of hours worked by our healthcare professionals, and growth in our other workforce solutions offerings during the three months ended June 30, 2015.

Locum tenens staffing segment revenue increased 31% to $97.4 million for the three months ended June 30, 2015 from $74.3 million for the same period in 2014. Of the $23.1 million increase, $8.9 million was attributable to the additional revenue in connection with the OH acquisition with the remainder primarily attributable to a 12% increase in the number of days filled and a 6% increase in revenue per day filled during the three months ended June 30, 2015.

Physician permanent placement services segment revenue increased 19% to $12.7 million for the three months ended June 30, 2015 from $10.7 million for the same period in 2014. The increase was primarily due to an increase in billable active searches and the average placement value during the three months ended June 30, 2015.

***Gross Profit.*** Gross profit increased 43% to $110.1 million for the three months ended June 30, 2015 from $77.2 million for the same period in 2014, representing gross margins of 31.4% and 30.8%, respectively. The increase in consolidated gross margin was due to an increase in gross margin in the nurse and allied healthcare staffing segment. The nurse and allied healthcare staffing segment increase in gross margin was primarily due to the addition of the higher margin Medefis business from the OH acquisition, the Avantas acquisition, and growth in our higher margin RPO and ShiftWise business lines during the three months ended June 30, 2015. The locum tenens staffing segment experienced a decrease in gross margin, which was primarily due to higher sales adjustments during the three months ended June 30, 2015. Gross margin by reportable segment for the three months ended June 30, 2015 and 2014 was 30.7% and 29.1% for nurse and allied healthcare staffing, 29.2% and 29.8% for locum tenens staffing, and 63.1% and 63.5% for physician permanent placement services, respectively.

***Selling, General and Administrative Expenses.*** Selling, general and administrative (“SG&A”) expenses were $74.7 million, representing 21.3% of revenue, for the three months ended June 30, 2015, as compared to $55.6 million, representing

22.1% of revenue, for the same period in 2014. The increase in SG&A expenses was primarily due to $7.8 million of additional SG&A expenses from the OH and Avantas acquisitions, $1.8 million of acquisition and integration costs, and higher expenses to support our growth, partially offset by a $3.3 million favorable actuarial-based decrease in our professional liability reserves as compared to a $1.6 million favorable decrease in the same period in 2014. SG&A expense increases in the nurse and allied healthcare staffing and locum tenens staffing segments were primarily attributable to $5.9 million and $1.6 million, respectively, of additional SG&A expenses from the acquisitions and higher expenses to support our growth. The increase in the unallocated corporate overhead was primarily attributable to $1.8 million of acquisition and integration costs, and higher employee and other expenses to support our growth. SG&A expenses broken down among the reportable segments, unallocated corporate overhead, and share-based compensation are as follows:

|  | (In Thousands) Three Months Ended June 30, 2015 | 2014 |
| --- | ---: | ---: |
| Nurse and allied healthcare staffing | $38,227 | $26,211 |
| Locum tenens staffing | 16,741 | 14,294 |
| Physician permanent placement services | 4,767 | 4,617 |
| Unallocated corporate overhead | 12,839 | 8,694 |
| Share-based compensation | 2,153 | 1,751 |
|  | $74,727 | $55,567 |

***Depreciation and Amortization Expenses.*** Amortization expense increased 53% to $2.9 million for the three months ended June 30, 2015 from $1.9 million for the same period in 2014, primarily attributable to additional amortization expense related to the intangible assets acquired in the OH and Avantas acquisitions. Depreciation expense increased 10% to $2.3 million for the three months ended June 30, 2015 from $2.1 million for the same period in 2014, primarily attributable to fixed assets acquired as part of the OH and Avantas acquisitions and an increase in purchased and developed hardware and software for our front and back office information technology initiatives.

***Interest Expense, Net, and Other.*** Interest expense, net, and other, was $2.0 million during the three months ended June 30, 2015 and $4.6 million during the three months ended June 30, 2014. The decrease is primarily due to a $3.1 million write-off of unamortized deferred financing fees and original issue discount for the three months ended June 30, 2014 in connection with the refinancing of our credit facilities that we entered into on April 18, 2014, partially offset by a higher average debt outstanding balance for the three months ended June 30, 2015, which resulted from our borrowings used to finance the OH acquisition. In addition, there was $0.3 million and $0.2 million of losses on equity method investment for the three months ended June 30, 2015 and 2014, respectively.

***Income Tax Expense.*** Income tax expense was $12.3 million for the three months ended June 30, 2015 as compared to income tax expense of $5.8 million for the same period in 2014, reflecting effective income tax rate of 44% for both periods. We currently estimate our annual effective income tax rate to be approximately 44% for 2015.

### Comparison of Results for the Six Months Ended June 30, 2015 to the Six Months Ended June 30, 2014

***Revenue.*** Revenue increased 38% to $677.7 million for the six months ended June 30, 2015 from $491.8 million for the same period in 2014, due to additional revenue of approximately $71.7 million resulting from our OH and Avantas acquisitions with the remainder of the increase driven by 23% organic growth.

Nurse and allied healthcare staffing segment revenue increased 42% to $469.1 million for the six months ended June 30, 2015 from $329.3 million for the same period in 2014. Of the $139.7 million increase, $55.8 million was attributable to the additional revenue in connection with the OH and Avantas acquisitions, with the remainder primarily attributable to a 12% increase in the average number of healthcare professionals on assignment, a 7% increase in the average bill rate, an increase in the average numbers of hours worked by our healthcare professionals, and growth in our other workforce solutions offerings during the six months ended June 30, 2015.

Locum tenens staffing segment revenue increased 30% to $184.1 million for the six months ended June 30, 2015 from $141.2 million for the same period in 2014. Of the $42.9 million increase, $15.9 million was attributable to the additional revenue in connection with the OH acquisition with the remainder primarily attributable to a 12% increase in the number of days filled and a 6% increase in revenue per day filled during the six months ended June 30, 2015.

Physician permanent placement services segment revenue increased 15% to $24.5 million for the six months ended June 30, 2015 from $21.3 million for the same period in 2014. The increase was primarily due to an increase in billable active searches and placements during the six months ended June 30, 2015.

***Gross Profit.*** Gross profit increased 40% to $211.6 million for the six months ended June 30, 2015 from $151.1 million for the same period in 2014, representing gross margins of 31.2% and 30.7%, respectively. The increase in consolidated gross margin was due to an increase in gross margin in both the nurse and allied healthcare staffing and physician permanent placement services segments. The nurse and allied healthcare staffing segment increase in gross margin was primarily due to the addition of the higher margin Medefis business from the OH acquisition, the Avantas acquisition, and growth in our higher margin RPO and ShiftWise business lines during the six months ended June 30, 2015. The physician permanent placement services segment increase was primarily due to lower recruiter compensation as a percentage of revenue during the six months ended June 30, 2015. The locum tenens staffing segment experienced a decrease in gross margin, which was primarily due to higher sales adjustments and lower bill to pay spreads during the six months ended June 30, 2015. Gross margin by reportable segment for the six months ended June 30, 2015 and 2014 was 30.2% and 29.0% for nurse and allied healthcare staffing, 29.3% and 29.8% for locum tenens staffing, and 64.4% and 63.3% for physician permanent placement services, respectively.

***Selling, General and Administrative Expenses.*** SG&A expenses were $146.3 million, representing 21.6% of revenue, for the six months ended June 30, 2015, as compared to $110.2 million, representing 22.4% of revenue, for the same period in 2014. The increase in SG&A expenses was primarily due to $14.8 million of additional SG&A expenses from the OH and Avantas acquisitions, $2.9 million of acquisition and integration costs, and higher expenses to support our growth, partially offset by a $3.3 million favorable actuarial-based decrease in our professional liability reserves as compared to a $2.1 million favorable decrease in the same period in 2014. SG&A expense increases in the nurse and allied healthcare staffing and locum tenens staffing segments were primarily attributable to $11.2 million and $2.9 million, respectively, of additional SG&A expenses from the acquisitions and higher expenses to support our growth. The increase in unallocated corporate overhead was primarily attributable to $2.9 million of acquisition and integration costs, and higher employee and other expenses to support our growth. SG&A expenses broken down among the reportable segments, unallocated corporate overhead, and share-based compensation are as follows:

|  | (In Thousands) Six Months Ended June 30, 2015 | 2014 |
| --- | ---: | ---: |
| Nurse and allied healthcare staffing | $74,517 | $53,576 |
| Locum tenens staffing | 33,141 | 27,384 |
| Physician permanent placement services | 9,227 | 9,142 |
| Unallocated corporate overhead | 24,864 | 16,562 |
| Share-based compensation | 4,530 | 3,570 |
|  | $146,279 | $110,234 |

***Depreciation and Amortization Expenses.*** Amortization expense increased 53% to $5.8 million for the six months ended June 30, 2015 from $3.8 million for the same period in 2014, primarily attributable to additional amortization expense related to the intangible assets acquired in the OH and Avantas acquisitions. Depreciation expense increased 13% to $4.5 million for the six months ended June 30, 2015 from $4.0 million for the same period in 2014, primarily attributable to fixed assets acquired as part of the OH and Avantas acquisitions and an increase in purchased and developed hardware and software for our front and back office information technology initiatives.

***Interest Expense, Net, and Other.*** Interest expense, net, and other, was $3.8 million during the six months ended June 30, 2015 and $6.5 million for the same period in 2014. The decrease is primarily due to a $3.1 million write-off of unamortized deferred financing fees and original issue discount for the six months ended June 30, 2014 in connection with the refinancing of our credit facilities that we entered into on April 18, 2014, partially offset by a higher average debt outstanding balance for the six months ended June 30, 2015, which resulted from our borrowings used to finance the OH acquisition. In addition, there were $0.5 million and $0.2 million of losses on equity method investment for the six months ended June 30, 2015 and 2014, respectively.

***Income Tax Expense.*** Income tax expense was $23.1 million for the six months ended June 30, 2015 as compared to income tax expense of $11.8 million for the same period in 2014, reflecting effective income tax rates of 45% and 44% for these periods, respectively. The increase in our effective income tax rate was primarily attributable to a one time discrete item that occurred during the six months ended June 30, 2015. We currently estimate our annual effective income tax rate to be approximately 44% for 2015.

### Liquidity and Capital Resources

In summary, our cash flows were:

|  | (In Thousands) Six Months Ended June 30, 2015 | 2014 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $33,687 | $7,041 |
| Net cash used in investing activities | (94,866) | (5,809) |
| Net cash provided by (used in) in financing activities | 62,592 | (11,265) |

Historically, our primary liquidity requirements have been for acquisitions, working capital requirements and debt service under our credit facilities. We have funded these requirements through internally generated cash flow and funds borrowed under our credit facilities. We are an obligor under a term loan and we maintain a revolving credit facility. At June 30, 2015, $140.6 million of our term loan was outstanding and $85.5 million was drawn under our revolving credit facility, with $130.1 million of available credit under our revolving credit facility. We describe in further detail our credit agreement under which our term loan and revolving credit facility are governed in “Item 8. Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Note (8), Notes Payable and Related Credit Agreement” of our 2014 Annual Report.

In April 2015, we entered into an interest rate swap agreement to minimize our exposure to interest rate fluctuations on $100 million of our outstanding variable rate debt under our term debt facility for which we pay a fixed rate of 0.983% per annum and receive a variable rate equal to floating one-month LIBOR. This agreement expires on March 30, 2018, and no initial investment was made to enter into this agreement.

We believe that cash generated from operations and available borrowings under our revolving credit facility will be sufficient to fund our operations for the next 12 months and beyond. We intend to finance potential future acquisitions either with cash provided from operations, borrowing under our revolving credit facility, bank loans, debt or equity offerings, or some combination of the foregoing. The following discussion provides further details of our liquidity and capital resources.

#### Operating Activities

Net cash provided by operating activities for the six months ended June 30, 2015 was $33.7 million, compared to $7.0 million for the same period in 2014. The increase in net cash provided by operating activities was primarily attributable to better operating results and an increase in accounts payable and accrued expenses between periods due to timing of payments. The increases were partially offset by increases in accounts receivable and accounts receivable for subcontractors. Our Days Sales Outstanding (“DSO”) was 60 days at June 30, 2015, 61 days at December 31, 2014, and 55 days at June 30, 2014.

#### Investing Activities

Net cash used in investing activities for the six months ended June 30, 2015 was $94.9 million, compared to $5.8 million for the same period in 2014. The increase was primarily due to our $76.9 million acquisition of OH in January 2015. Capital expenditures were $14.6 million and $9.9 million for the six months ended June 30, 2015 and 2014, respectively. The increase in capital expenditures was primarily to support growth in the business and our initiative to enhance our front and back office information technology platforms, including PeopleSoft and Salesforce, and the integration of the OH and Avantas acquisitions.

#### Financing Activities

Net cash provided by financing activities during the six months ended June 30, 2015 was $62.6 million, primarily due to borrowing under our revolving credit facility to fund our OH acquisition, partially offset by repayment of $3.8 million under our term loan and $17 million under our revolving credit facility and cash paid for shares withheld for payroll taxes resulting from the vesting of employee equity awards. Net cash used in financing activities during the six months ended June 30, 2014 was $11.3 million, primarily due to repayments of our debt, including both regularly scheduled payments and paying off our prior credit facilities, and cash paid for shares withheld for payroll taxes resulting from the vesting of employee equity awards, partially offset by the borrowings under the new credit facilities.

Excluding the effects of the interest rate swap on our term loan facility, the annual interest rate for amounts outstanding under both our term loan and revolving credit facilities was 2.19% on a LIBOR basis as of June 30, 2015.

#### Letters of Credit

At June 30, 2015, we maintained outstanding standby letters of credit totaling $15.0 million as collateral in relation to our professional liability insurance agreements, workers’ compensation insurance agreements, and a corporate office lease agreement. Of the $15.0 million of outstanding letters of credit, we have collateralized $5.6 million in cash, cash equivalents and investments and the remaining amounts are collateralized by our revolving credit facility. Outstanding standby letters of credit at December 31, 2014 totaled $15.0 million.

### Off-Balance Sheet Arrangements

At June 30, 2015, we did not have any off-balance sheet arrangement that has or is reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

### Contractual Obligations

There have been no material changes to the table entitled “Contractual Obligations” in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” set forth in our 2014 Annual Report that have occurred during the six months ended June 30, 2015 with the exception of an increase of approximately $67.5 million in the amount outstanding under our revolving credit facility, which resulted from our borrowings used to finance the OH acquisition. As of June 30, 2015, the total amount outstanding under our revolving credit facility was $85.5 million. Of this amount, $30 million was classified as current at June 30, 2015, based on management intentions to repay this amount during the next 12 months. The maturity date of our revolving credit facility is in 2019.

### Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance provides that the standard will be effective for us beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. In July 2015, the FASB voted to amend the guidance by approving a one-year delay in the effective date of the new standard to 2018. Under this deferred implementation, early adoption is allowed, but not earlier than the original effective date. We are currently evaluating the timing of its adoption and the effect that adopting this new standard will have on our financial statements and related disclosures.

In April 2015, the FASB issued ASU 2015-03, “Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs.” The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset. Debt disclosures will include the face amount of the debt liability and the effective interest rate. The update requires retrospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2015 and early adoption is permitted. The adoption will not have a material effect on our consolidated financial statements as it will only result in a reclassification of our capitalized loan costs from other long-term assets to offset our debt balance.

In April 2015, the FASB issued ASU 2015-05, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement.” This standard provides guidance about whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a software license, then the software license element of the arrangement should be accounted for by the customer consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract. ASU 2015-05 is effective for fiscal years beginning after December 15, 2015, and interim periods within those years. This standard can be adopted either prospectively to all arrangements entered into or materially modified after the effective date or retrospectively. We are currently evaluating the effect that adopting this new standard will have on our financial statements and related disclosures.

There have been no other new accounting pronouncements issued but not yet adopted that are expected to materially affect our consolidated financial condition or results of operations.

### Special Note Regarding Forward-Looking Statements

This Quarterly Report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We based these forward-looking statements on our expectations, estimates, forecasts and projections about future events and about the industry in which we operate. Forward-looking statements are identified by words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “should,” “would,” “project,” “may,” variations of such words and other similar expressions. In addition, any statements that refer to projections of financial items, anticipated growth, future growth and revenues, future economic conditions and performance, plans, objectives and strategies for future operations, expectations, or other characterizations of future events or circumstances are forward-looking statements. All forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ materially from those implied by the forward-looking statements in this Quarterly Report are set forth in our 2014 Annual Report and include but are not limited to:

- the effects of economic downturns or slow recoveries, which could result in less demand for our services;
- any inability on our part to maintain existing and secure new contracts directly with our clients or through group purchasing organizations;
- the level of consolidation and concentration of buyers of healthcare workforce solutions and staffing services, which could affect the pricing of our services and our ability to mitigate risk;
- any inability on our part to quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement or client needs;
- the ability of our clients to retain and increase the productivity of their permanent staff, or their ability to increase the efficiency and effectiveness of their internal recruiting efforts, through online recruiting or otherwise, which may negatively affect the demand for our services;
- our ability to grow and operate our business profitably in compliance with federal and state healthcare industry regulation including conduct of operations, and costs and payment for services and payment for referrals as well as laws regarding employment practices and government contracting;
- any significant negative effects on our business arising from federal legislation, including the Patient Protection and Affordable Care Act of 2010, regarding the current delivery and third-party payor system for healthcare;
- the challenge to the classification of certain of our healthcare professionals as independent contractors, which could adversely affect our profitability;
- the effect of medical malpractice, employment and wage regulation and other claims asserted against us, which could subject us to substantial liabilities;
- any inability on our part to safely secure private information, which could subject us to substantial liabilities;
- any inability on our part to implement new infrastructure and technology systems effectively, which may adversely affect our operating results and our ability to manage our business effectively;
- the effect of technology disruptions and obsolescence, which may negatively affect our business operations;
- any inability on our part to recruit and retain sufficient quality healthcare professionals at reasonable costs;
- any inability on our part to properly screen and match healthcare professionals with suitable placements;
- any inability on our part to successfully attract and retain a sufficient number of quality sales and operational personnel;
- the loss of our key officers and management personnel;
- any inability on our part to maintain our positive brand awareness and identity;
- any recognition by us of an impairment to goodwill or indefinite-lived intangibles;
- the effect of significant adverse adjustments by us to our tax and insurance-related accruals, which could decrease our earnings or increase our losses, as the case may be, or negatively affect our cash flow; and
- our level of indebtedness and any inability on our part to generate sufficient cash flow to service our debt.

## Market risk

As filed, 950 characters.

Market risk is the risk of loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates and commodity prices. During the six months ended June 30, 2015, our primary exposure to market risk was interest rate risk associated with our variable interest debt instruments. In April 2015, we entered into an interest rate swap agreement to minimize our exposure to interest rate fluctuations on $100 million of our outstanding variable rate debt under our term debt facility for which we pay a fixed rate of 0.983% per annum and receive a variable rate equal to floating one-month LIBOR. This agreement expires on March 30, 2018, and no initial investment was made to enter into it. A 100 basis point increase in interest rates on our variable rate debt would not have resulted in a material effect on our unaudited condensed consolidated financial statements for the six months ended June 30, 2015.

## Controls and procedures

As filed, 1,196 characters.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of June 30, 2015 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 135 characters.

We do not believe that there have been any material changes to the risk factors disclosed in Part I, Item 1A of our 2014 Annual Report.

Filed Aug 6, 2015.
Source: SEC EDGAR, the filing index for accession 0001142750-15-000009. Last ingested by Listed: Nov 5, 2026, 17:59 ET. No prices; not investment advice.
